North America Malaria Treatment Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Treatment (Generic Drugs, Originators, Vaccines, and Others), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)

No. of Pages: 84    |    Report Code: TIPRE00025040    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Malaria Treatment Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Malaria Treatment Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Malaria Treatment Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Prevalence of Malaria
  • 5.1.2 Rising Initiatives to Raise Awareness about Malaria
5.2 Market Opportunities
  • 5.2.1 Growing Strategic Initiatives by Market Players
5.3 Future Trends
  • 5.3.1 Extending Pipeline of New Drugs and Vaccines
5.4 Impact of Drivers and Restraints

6. North America Malaria Treatment Market Regional Analysis

6.1 North America Malaria Treatment Market Overview
6.2 North America Malaria Treatment Market Revenue 2020-2030 (US$ Million)
6.3 North America Malaria Treatment Market Forecast Analysis

7. North America Malaria Treatment Market Analysis – by Treatment

7.1 Generic Drugs
  • 7.1.1 Overview
  • 7.1.2 Generic Drugs: North America Malaria Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Originators
  • 7.2.1 Overview
  • 7.2.2 Originators: North America Malaria Treatment Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Vaccines
  • 7.3.1 Overview
  • 7.3.2 Vaccines: North America Malaria Treatment Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Malaria Treatment Market Analysis – by Route of Administration

8.1 Oral
  • 8.1.1 Overview
  • 8.1.2 Oral: North America Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Parenteral
  • 8.2.1 Overview
  • 8.2.2 Parenteral: North America Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Malaria Treatment Market Analysis – by Distribution Channel

9.1 Direct Tender
  • 9.1.1 Overview
  • 9.1.2 Parenteral: North America Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Hospital Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Parenteral: North America Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Retail Pharmacies
  • 9.3.1 Overview
  • 9.3.2 Parenteral: North America Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Online Pharmacies
  • 9.4.1 Overview
  • 9.4.2 Parenteral: North America Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Malaria Treatment Market – North America Analysis

10.1 North America
  • 10.1.1 North America Malaria Treatment Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 North America Malaria Treatment Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 US: North America Malaria Treatment Market Breakdown, by Treatment
    • 10.1.1.1.2 US: North America Malaria Treatment Market Breakdown, by Route of Administration
    • 10.1.1.1.3 US: North America Malaria Treatment Market Breakdown, by Distribution Channel
  • 10.1.1.2 Canada: North America Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Canada: North America Malaria Treatment Market Breakdown, by Treatment
    • 10.1.1.2.2 Canada: North America Malaria Treatment Market Breakdown, by Route of Administration
    • 10.1.1.2.3 Canada: North America Malaria Treatment Market Breakdown, by Distribution Channel
  • 10.1.1.3 Mexico : North America Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Malaria Treatment Market Breakdown, by Treatment
    • 10.1.1.3.2 Mexico : North America Malaria Treatment Market Breakdown, by Route of Administration
    • 10.1.1.3.3 Mexico : North America Malaria Treatment Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Malaria Treatment Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Cipla Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Sun Pharmaceutical Industries Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Sanofi SA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 GSK Plc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Novartis AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Pfizer Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 AdvaCare Pharma USA LLC
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 VLP Therapeutics LLC
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Lupin Ltd
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

1. Cipla Ltd
2. Sun Pharmaceutical Industries Ltd
3. Sanofi SA
4. GSK Plc
5. Novartis AG
6. Pfizer Inc
7. AdvaCare Pharma USA LLC
8. VLP Therapeutics LLC
9. Lupin Ltd

north-america-malaria-treatment-market